NYSE:PFE - Pfizer Stock Price, News, & Analysis

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Pfizer declared a quarterly dividend on Thursday, September 27th. Shareholders of record on Friday, November 9th will be paid a dividend of $0.34 per share on Monday, December 3rd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 3.08%. The ex-dividend date is Thursday, November 8th. View Pfizer's Dividend History.

Pfizer declared that its board has approved a stock buyback program on Tuesday, December 19th 2017, which authorizes the company to buyback $10,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company's board of directors believes its stock is undervalued.

Pfizer Inc. (NYSE:PFE) announced its quarterly earnings results on Tuesday, October, 30th. The biopharmaceutical company reported $0.78 earnings per share for the quarter, beating analysts' consensus estimates of $0.75 by $0.03. The biopharmaceutical company earned $13.30 billion during the quarter, compared to the consensus estimate of $13.53 billion. Pfizer had a net margin of 44.63% and a return on equity of 25.26%. The business's quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.67 EPS. View Pfizer's Earnings History.

Pfizer is scheduled to release their next quarterly earnings announcement on Tuesday, January 29th 2019. View Earnings Estimates for Pfizer.

Pfizer issued an update on its FY18 earnings guidance on Tuesday, October, 30th. The company provided EPS guidance of $2.98-3.02 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.99. The company issued revenue guidance of $53-53.7 billion, compared to the consensus revenue estimate of $54.16 billion.

22 brokers have issued 1 year price objectives for Pfizer's stock. Their predictions range from $37.00 to $53.00. On average, they anticipate Pfizer's stock price to reach $43.00 in the next year. This suggests that the stock has a possible downside of 2.7%. View Analyst Price Targets for Pfizer.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last year. There are currently 2 sell ratings, 13 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Pfizer.

News headlines about PFE stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Pfizer earned a daily sentiment score of 2.0 on InfoTrie's scale. They also gave media stories about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days.

Pfizer saw a decline in short interest during the month of October. As of October 31st, there was short interest totalling 46,551,071 shares, a decline of 7.5% from the October 15th total of 50,351,438 shares. Based on an average trading volume of 26,087,863 shares, the days-to-cover ratio is presently 1.8 days. Approximately 0.8% of the company's stock are short sold. View Pfizer's Current Options Chain.

Some companies that are related to Pfizer include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Novartis (NVS), AbbVie (ABBV), Abbott Laboratories (ABT), Eli Lilly And Co (LLY), Sanofi (SNY), Novo Nordisk A/S (NVO), AstraZeneca (AZN), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Shire (SHPG), Allergan (AGN) and Celgene (CELG).

Pfizer's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.57%), Capital World Investors (1.43%), Bank of New York Mellon Corp (1.18%), Massachusetts Financial Services Co. MA (1.01%), Dimensional Fund Advisors LP (0.90%) and Fisher Asset Management LLC (0.68%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Charles H Hill, Douglas M Lankler, Frank A Damelio, Ian C Read, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Pfizer Inc, Rady A Johnson, Sally Susman and W Don Cornwell. View Institutional Ownership Trends for Pfizer.

PFE stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Mitsubishi UFJ Trust & Banking Corp, Nordea Investment Management AB, BlackRock Inc., American Century Companies Inc., FMR LLC, The Manufacturers Life Insurance Company and Epoch Investment Partners Inc.. Company insiders that have sold Pfizer company stock in the last year include Alexander R Mackenzie, Charles H Hill, Douglas M Lankler, Frank A Damelio, Ian C Read, Kirsten Lund-Jurgensen, Laurie J Olson, Loretta V Cangialosi, Mikael Dolsten, Rady A Johnson, Sally Susman and W Don Cornwell. View Insider Buying and Selling for Pfizer.

PFE stock was purchased by a variety of institutional investors in the last quarter, including Capital World Investors, AQR Capital Management LLC, Bessemer Group Inc., Bank of New York Mellon Corp, Canada Pension Plan Investment Board, Assenagon Asset Management S.A., Glenmede Trust Co. NA and Skandinaviska Enskilda Banken AB publ . View Insider Buying and Selling for Pfizer.

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PFE stock can currently be purchased for approximately $44.18.

Pfizer has a market capitalization of $259.01 billion and generates $52.55 billion in revenue each year. The biopharmaceutical company earns $21.31 billion in net income (profit) each year or $2.65 on an earnings per share basis. Pfizer employs 90,200 workers across the globe.

The official website for Pfizer is http://www.pfizer.com.

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.